Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Evelo announces IND application to study EDP-1815 for COVID-19

May 8, 2020

FDA approves the initiation of phase II COVID-19 studies of PUL-042

May 8, 2020

Roche patents new antivirals for HBV infection

May 8, 2020

Remdesivir receives Japanese approval for severe COVID-19

May 8, 2020

MGH reports progress in development of a novel gene-based COVID-19 vaccine

May 8, 2020

DongWha Pharm plans phase II evaluation of DW-2008 for COVID-19

May 7, 2020

New phase III study evaluates lenzilumab in hospitalized patients with COVID-19

May 7, 2020

TGen and HonorHealth initiate study of atovaquone plus azithromycin in COVID-19

May 7, 2020

Merck & Co. presents data from RESTORE-IMI 2 phase III study of Recarbrio

May 7, 2020

Health Canada clears initiation of phase II study of LAU-7b for COVID-19

May 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...